研究者
J-GLOBAL ID：202201010196130280
更新日: 2024年07月10日
清水 陽介
シミズ ヨウスケ | Shimizu Yosuke
所属機関・部署：
職名：
上級研究員
論文 (24件)：
-
Nobumasa Okumura, Eriko Morino, Hidetoshi Nomoto, Mashiho Yanagi, Kozue Takahashi, Haruka Iwasaki, Yukari Uemura, Yosuke Shimizu, Daisuke Mizushima, Kazuaki Fukushima, et al. Safety and Effectiveness of LC16m8 for Pre-Exposure Prophylaxis against mpox in a High-Risk Population: An Open-Label Randomized Trial. 2024
-
Eriko Morino, Sohtaro Mine, Noriko Tomita, Yukari Uemura, Yosuke Shimizu, Sho Saito, Tetsuya Suzuki, Nobumasa Okumura, Haruka Iwasaki, Junko Terada, et al. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults. NEJM evidence. 2024. 3. 3. EVIDoa2300290
-
Takashi Ishiguro, Yoichi Kobayashi, Yosuke Shimizu, Yukari Uemura, Riho Toriba, Naomi Takata, Miyuki Ueda, Yoshihiko Shimizu. Prognostic factors of virus-associated pneumonia other than COVID-19 in adults. Respiratory Medicine. 2024
-
Yukari Uemura, Ryoto Ozaki, Tomohiro Shinozaki, Hiroshi Ohtsu, Yousuke Shimizu, Kazuo Izumi, Sho Saito, Nobuaki Matsunaga, Norio Ohmagari. Comparative effectiveness of tocilizumab vs standard care in patients with severe COVID-19-related pneumonia: a retrospective cohort study utilizing registry data as a synthetic control. BMC infectious diseases. 2023. 23. 1. 849-849
-
Naokatsu Ando, Daisuke Mizushima, Yosuke Shimizu, Yukari Uemura, Misao Takano, Morika Mitobe, Kai Kobayashi, Hiroaki Kubota, Hirofumi Miyake, Jun Suzuki, et al. Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial. JMIR Research Protocols. 2023
もっと見る
前のページに戻る
